Northwest Biotherapeutics Inc
NWBO
Revenue
510.00k
▲226.00k▲79.58%
3 Months ChangeAssets
28.23M
▼-342.00k▼-1.20%
3 Months ChangeLiabilities
85.97M
▲3.93M▲4.79%
3 Months ChangeFree Cash Flow
-18.72M
▼-8.16M▼-77.24%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001104659-24-113553
2024-08-09
Form 10-Q
ID: 0001410578-24-001278
2024-08-02
Form 8-K
ID: 0001104659-24-085198
2024-07-03
Form 8-K
ID: 0001104659-24-077718
2024-06-04
Form 8-K
ID: 0001104659-24-068314
2024-05-10
Form 10-Q
ID: 0001410578-24-000741
2024-05-02
Form 8-K
ID: 0001104659-24-056424
2024-03-22
Form 8-K
ID: 0001104659-24-037901
2024-03-14
Form 8-K
ID: 0001104659-24-034527
2023-11-16
Form 8-K
ID: 0001104659-23-119165